Patient Research
Find a studySpecialtiesConditionsTreatmentsBy countryLearn
Sign in
All treatments
Treatment

STELARA 90 mg solution for injection in pre-filled pen, STELARA 130 mg concentrate for solution for infusion clinical trials

1 indexed studies · 0 currently recruiting

  • AuthorisedTherapeutic exploratory (Phase II)

    Giving Upfront Anti-p40 to Reduce toxicity from Dual Immune Checkpoint Inhibition in MESOthelioma

    This clinical trial is testing whether a medicine called Stelara can reduce severe side effects in people receiving two immunotherapy drugs for pleural mesothelioma. Pleural mesothelioma is cancer of the chest lining. Researchers want to see if adding Stelara makes treatment safer without stopping the cancer therapy from working.

    For: Pleural mesothelioma
    Netherlands
Advertisement
Advertisement
Advertisement
Patient.info Research

Find clinical research studies and trials explained in plain English - powered by Patient.info.

About
  • About us
  • Advertise with us
  • Partnerships
  • Authors
  • Contact us
Research explained
  • What is a clinical trial?
  • Trial phases explained
  • Why volunteer?
  • Clinical research FAQ
  • All health-research articles
Legal
  • About our content
  • Report a correction
  • Accessibility statement
  • Cookie policy
  • Privacy policy
  • Terms of use
  • Editorial policy
Find a study

Search clinical research studies and trials by condition, location and eligibility.

Browse studies →Learn about trials →
Information only. Research.Patient.info surfaces public clinical-trial registry data and explains it in plain English. We are not affiliated with the MHRA, HRA, NHS, NIHR or any regulator. Inclusion of a study is not an endorsement and is not medical advice — always discuss with your own doctor before agreeing to take part. See about our content or report a correction.
© 2026 Navigate Health Ltd. All rights reserved.
Registered number: 16229589
Registered office: 128 City Road, London, United Kingdom, EC1V 2NX.
Patient is a UK registered trade mark.
Patient does not provide medical advice, diagnosis or treatment.